Drug Database
IN

Integra Artificial Skin

✓ Approved

Integra LifeSciences · therapeutic agent

What is Integra Artificial Skin?

Integra Artificial Skin is a therapeutic agent developed by Integra LifeSciences. It is approved for therapeutic indications via others.

Drug Profile

CompanyIntegra LifeSciences
RouteOthers
StatusApproved

Therapeutic Indications

Integra Artificial Skin is developed for 3 unique indications across 3 therapeutic areas.

Therapeutic AreaConditionPhase
General disorders and administration site conditionsImpaired healing✓ Approved
Injury, poisoning and procedural complicationsThermal burn✓ Approved
Surgical and medical proceduresAdjuvant therapy✓ Approved

Related Research Articles

PubMedJournal of agromedicine2026-08-30

Skin Cancer in Rural Workers in Brazil: Influence of Ultraviolet Radiation, Skin Color and Regional Factors.

Moraes Rufini de Souza Lucas L, Minette Luciano José LJ, Schettino Stanley S, de Almeida Guimarães Marcelo M et al.

This study analyzed the incidence of skin cancer among rural workers in Brazil, considering the influence of ultraviolet (UV) radiation, skin color, and regional factors. Data from the National Cancer Institute (2008-2022) on skin cancer were used, using historical series of the Ultraviolet Index (UVI) obtained via satellite and cross-referenced with population information obtained from the Brazilian Institute of Geography and Statistics. Between 2008 and 2022, Brazil recorded 81,378 cases of skin cancer related to rural workers, with an average incidence rate of 318.23 cases per 100,000. The UVI is high in the North and North-East regions of the country, but the highest rate of skin cancer occurs in the South, where 73% of the population is white and the UVI is lower. Correlation and regression analyses revealed that the UVI, the proportion of white people, and the percentage of rural workers significantly influence the skin cancer rate. These results show that approximately 28% of a rural worker's risk of developing skin cancer may be related to the interaction between biological and environmental factors and that prevention and sun protection strategies should take into account demographic and regional variability.

PubMedCureus2026-08-30

Beyond Melanin: A Literature Review of Photoprotection Mechanisms and Gaps in Skin of Color.

Leybengrub Pamella P, Eyob Wintana W, Petrossian Lina L, Shetty Saumya S et al.

There is a critical need for tailored photoprotection in skin of color (SOC) populations. SOC has higher eumelanin-to-phenomelanin ratios, more mature melanosomes, and enhanced DNA repair capacity compared with lighter skin. The quantity and distribution of melanin in darker skin provide natural photoprotection. This leads to a misconception that SOC populations are inherently protected from all photodamage and serves as a barrier to proper photoprotection for these populations. Although the skin cancer incidence is lower in dark skin, mortality is higher, perhaps as a result of late diagnosis or misdiagnosis. These populations are still susceptible to skin damage from ultraviolet (UV) radiation, resulting in exacerbation of various dermatologic conditions, including pigmentation disorders, photodermatoses, and skin cancer. This review aims to comprehensively examine the photoprotection needs for SOC populations, addressing gaps between physiological characteristics and clinical outcomes, evaluating current photoprotection practices, examining educational implications, and considering future directions for photoprotection for SOC. A literature search was performed using PubMed and Google Scholar. The search was conducted from database inception through July 15, 2026. Articles were included if they addressed photoprotection, photodamage, photoaging, pigmentary disorders, photodermatoses, or skin cancer in SOC populations. Visible light (VL) and long-wave UVA1 are significant contributors to pigmentary alteration in SOC. The major drivers of pigmentation in SOC and photodamage can manifest as pigmentary disorders, particularly melasma and post-inflammatory hyperpigmentation (PIH), photoaging, photodermatoses, and skin cancer risk. Comprehensive photoprotection strategies for individuals with SOC include behavioral sun avoidance measures, sun-protective clothing, avoiding harmful behaviors, and community-based education programs. Sunscreen formulations for SOC should be tailored to skin phototype (SPT), with an SPF of 30 and broad protection that covers UVA, VL, and infrared A to limit hyperpigmentation and photoaging. Iron oxide-containing sunscreens provide VL protection and reduce white cast. Niacinamide-containing sunscreens are helpful for reducing PIH. Since UV and VL generate reactive oxygen species (ROS) that promote inflammation and persistent PIH, antioxidants in sunscreen are important in SOC to neutralize this damage and support DNA repair. Comprehensive photoprotection is essential for SOC populations. SOC individuals face unique manifestations of photodamage. Effective photoprotection in SOC requires extension beyond traditional UVB protection to meet the specific needs of SOC. Additionally, targeted education, community engagement, and barriers to care need to be addressed to improve outcomes. It is important for the dermatology community to commit to inclusivity and advocate for equitable access to photoprotection resources for all.

PubMedNature communications2026-08-30

Navigating regulatory fragmentation in the convergence of synthetic biology, artificial intelligence, and automation.

McLennan Ross K J RKJ, Freemont Paul S PS, Pretorius Isak S IS

The convergence of synthetic biology, artificial intelligence (AI), and automation (SynBioxAI) creates research activities that simultaneously engage biosecurity, AI governance, export control, and data sovereignty frameworks - none of which are designed for convergent science. We conduct a comprehensive cross-jurisdictional analysis of this regulatory landscape across sixteen nations, identifying critical ambiguities where novel SynBioxAI objects fall between established regulatory categories. Through seven realistic collaboration scenarios, we demonstrate that regulatory friction is multiplicative rather than additive. We propose the SynBioxAI Regulatory Interoperability Toolkit (RIOT): a practical, seven-lens institutional framework that gives research institutions the capacity to navigate regulatory divergence efficiently and transparently.

PubMedHardwareX2026-08-30

Low-Cost and Tough Pneumatic Artificial Muscle (LT-PAM).

Naniwa Keisuke K, Sugimoto Yasuhiro Y, Nakanishi Daisuke D, Masuda Yoichi Y

Pneumatic artificial muscles (PAMs) are widely used as soft actuators in biomechanics and robotics, yet their adoption in laboratories is often hindered by skill-dependent fabrication processes or reliance on costly commercial products. This article presents an open-source Low-Cost and Tough Pneumatic Artificial Muscle (LT-PAM) designed for research and educational use, with an emphasis on ease of fabrication, reproducibility, and mechanical robustness. The actuator uses a silicone inner tube, a braided sleeve, and mechanically crimped metal fittings that eliminate the need for adhesive bonding in load-bearing connections. All components are assembled from off-the-shelf parts and simple 3D-printed end plugs, enabling rapid and repeatable in-house fabrication. The basic mechanical characteristics are evaluated through quasi-static force-length tests under constant pressure and pressure-contraction tests under constant load, confirming canonical McKibben-type behavior with low sample-to-sample variability. Rupture tests and long-term cyclic tests further demonstrate robustness, with specimens sustaining tensile loads of approximately 600-800 N and surviving more than 9000 pressurization cycles without catastrophic failure. These results indicate that the LT-PAM is a practical, low-cost, and reproducible soft actuator for experiments with high-load soft robots, including musculoskeletal robotic systems.

PubMedJournal of human lactation : official journal of International Lactation Consultant Association2026-08-30

Exploring the Efficacy and Safety of a Nursing Gel Formulation in Pregnant and Lactating Women With Cracked and Painful Nipples: An Open-Label, Single-Arm Clinical Study.

Patel Trupti T, Prajapati Ramesh R, Narkhede M Virendra V, Bhimani Rutu R et al.

Breastfeeding women often experience nipple pain, usually caused by incorrect newborn positioning in the first 10 days after childbirth. To explore the efficacy and safety of a novel gel-based formulation in healthy pregnant and lactating women with cracked and painful nipples. Sixty participants were instructed to gently apply approximately 0.5 g of test product onto the nipples and surrounding area for 14 days (an open-label, single-arm study). Nipple pain, nipple skin physical parameters, skin hydration, and skin barrier function were assessed at various time points. The nipple pain significantly reduced at all visits following the application of the test product, with a 43.7% decrease by 24 hours (Day 2; p < 0.0001) and a complete relief at Day 14 (p < 0.0001) after application of the test product compared to the baseline. The dermatological assessment of nipple skin conditions revealed a significant improvement in dryness, nipple skin roughness, nipple skin redness/erythema, burning, itching, and stinging at all visits compared to the baseline. Skin hydration significantly improved by 23.55% by 24 hours (p < 0.0001) and 42.25% at Day 14 (p < 0.0001) as compared to baseline. Additionally, trans-epidermal water loss (TEWL) significantly reduced by 8.78% by 24 hours (p < 0.0001) and 21.52% at Day 14 (p < 0.0001) as compared to baseline. The gel-based formulation was well-tolerated and safe, with participants showing marked improvement in nipple symptoms within 24 hours and complete resolution by Day 14. These findings are preliminary and further controlled studies are needed to confirm the results.Clinical trial registry name:Clinical Trials Registry-IndiaURL:www.ctri.nic.in. CTRI/2022/08/044645.

PubMedZhonghua wai ke za zhi [Chinese journal of surgery]2026-08-30

[Advances and prospects of hemostatic strategies in hepatic surgery].

Xie T A TA, Peng S Y SY, Hou X T XT, Cai X J XJ

The liver is characterized by abundant blood supply and intricate anatomical architecture,rendering intraoperative and postoperative hemorrhage a primary clinical challenge. Conventional compression and suture ligation fail to enable precise perioperative hemorrhage prediction. Driven by the integration of precision medicine,artificial intelligence,and biomaterials,hemostatic strategies are undergoing a paradigm shift from passive compression to precise targeted intervention. This paper systematically reviews advances and future perspectives in hemostatic strategies for hepatic surgery. Preoperative individualized intervention is achieved via tranexamic acid prophylaxis,portal vein embolization,and radiological assessment; intraoperatively,Peng's curettage-suction technique enhances hemorrhage control; postoperatively,tiered "pharmacological-interventional-surgical" management allows proactive whole-course hemostatic regulation. Looking ahead,nano-drug delivery systems coupled with artificial intelligence closed-loop frameworks will facilitate the integrated development of hemostasis,liver regeneration promotion,and postoperative recurrence inhibition.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about Integra Artificial Skin